Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
NCT02684591
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Nonalcoholic Fatty Liver Disease
HIV
Interventions
DRUG:
Aramchol
DRUG:
Placebo
Sponsor
University of California, San Diego